We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Biology Technique Detects the 2009 H1N1 Virus

By LabMedica International staff writers
Posted on 07 Jul 2010
A new polymerase chain reaction (PCR) diagnostic test can detect human infections with 2009 H1N1 virus with sensitivity and specificity greater than 96% for upper respiratory specimens.

The test is used to isolate and amplify viral genetic material present in secretions taken from a patient's upper or lower respiratory tract. Upper respiratory specimens are easily obtainable in a doctor's office, and lower respiratory specimens are typically obtained from severely ill patients in a hospital setting.

Amplified viral genetic material generates a fluorescent signal, which is then detected and analyzed by a diagnostic instrument called the Applied Biosystems 7500 Fast DX Realtime PCR Instrument. The test panel and diagnostic system can provide results within four hours, and multiple samples can be tested at the same time.

The new test was developed by the [U.S.] Centers for Control and Prevention of Disease (CDC; Atlanta, GA, USA). It is called the "CDC Influenza 2009 A (H1N1) pdm Real-Time RT-PCR Panel (IVD)," and it will help ensure the accuracy of influenza testing results among the different qualified laboratories that conduct influenza subtype testing in the United States and abroad. The test was authorized for use by the U.S. Food and Drug Administration.

The test will replace the previous real-time RT-PCR diagnostic test used during the 2009 H1N1 pandemic, called the "Swine Influenza Virus Real-time RT-PCR Detection Panel (rRT-PCR Swine Flu Panel)," which received an emergency use authorization by the U.S. Food and Health Administration (FDA; Silver Spring, MD, USA) in April 2009.

The earlier test was developed based on the limited number of 2009 H1N1 specimens available at the start of the 2009 H1N1 pandemic in April 2009. The new test has been optimized using the vast amount of 2009 H1N1 genetic information CDC received throughout the pandemic.

Related Links:
Applied Biosystems
[U.S.] Centers for Control and Prevention of Disease
U.S. Food and Health Administration




New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Clinical Chemistry System
P780
New
Gold Member
Hematology Analyzer
Medonic M32B

Latest Microbiology News

Saliva Test Detects Implant-Related Microbial Risks
07 Jul 2010  |   Microbiology

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
07 Jul 2010  |   Microbiology

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
07 Jul 2010  |   Microbiology



PURITAN MEDICAL